CA
NZ
UK
AU
IND
US
● The company has a market value of about $21.5 million.
● The decline more than erased Wednesday's spike.
● Tyra is a clinical-stage biotech developing precision medicines.
● The premarket figure is a snapshot, not a closing price.
● The FDA lifted the clinical hold on ARD-101 for Prader-Willi syndrome.
● The biotechnology company had no company-specific news.
● Health care closed at a record high even as the broader market slumped.
● The noteholder forbearance period was set to expire at 11:59 PM ET that day.
● Medicare began paying $1,938.01 per EsoGuard test.
● The Phase 3 trial tested the vaccine alongside Merck's Keytruda in over 1,100 patients.
Please wait processing your request...